Literature DB >> 30926409

Symptom Clusters of Neuropsychiatric Symptoms in Mild Cognitive Impairment and Their Comparative Risks of Dementia: A Cohort Study of 8530 Older Persons.

Tau Ming Liew1.   

Abstract

OBJECTIVES: Neuropsychiatric symptoms (NPS) have been recognized to increase the risk of dementia among individuals with mild cognitive impairment (MCI). However, it is unclear whether the risk is shared across the various NPS or driven primarily by selected few symptoms. This study sought to provide confirmatory evidence on the comparative risk of dementia across the various NPS in MCI.
DESIGN: Cohort study (median follow-up 4.0 years; interquartile range 2.1-6.4 years).
SETTING: Alzheimer's Disease Centers across the United States. PARTICIPANTS: Participants ≥60 years of age and diagnosed with MCI at baseline (n = 8530). MEASURES: Participants completed the Neuropsychiatric Inventory-Questionnaire at baseline and were followed up almost annually for incident dementia. Symptom clusters of NPS, as identified from confirmatory factor analyses, were included in Cox regression to investigate their comparative risks of dementia.
RESULTS: Three symptom clusters of NPS were identified among participants with MCI, namely hyperactivity, affective, and psychotic symptoms. The risk of dementia was present among participants with affective symptoms [hazard ratio (HR) 1.6, 95% confidence interval (CI) 1.4-1.9] and psychotic symptoms (HR 1.6, 95% CI 1.2-2.2), but not among those with hyperactivity symptoms (HR 1.1, 95% CI 0.9-1.3). The risk was higher when affective symptoms and psychotic symptoms co-occurred (HR 2.5, 95% CI 2.0-3.2), with one-half of the participants in this group developing dementia within 2.7 years of follow-up. CONCLUSIONS AND IMPLICATIONS: The findings illustrate the potential usefulness of NPS as a convenient prognostic tool in the clinical management of MCI. They also suggest the need for future research to focus on affective/psychotic symptoms in MCI when studying the neurobiological links between NPS and neurodegenerative processes.
Copyright © 2019 AMDA – The Society for Post-Acute and Long-Term Care Medicine. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cox regression; Mild cognitive impairment; cohort study; comparative risk; dementia; neuropsychiatric symptoms

Year:  2019        PMID: 30926409      PMCID: PMC6663577          DOI: 10.1016/j.jamda.2019.02.012

Source DB:  PubMed          Journal:  J Am Med Dir Assoc        ISSN: 1525-8610            Impact factor:   4.669


  31 in total

Review 1.  El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis.

Authors:  B R Brooks; R G Miller; M Swash; T L Munsat
Journal:  Amyotroph Lateral Scler Other Motor Neuron Disord       Date:  2000-12

2.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician.

Authors:  M F Folstein; S E Folstein; P R McHugh
Journal:  J Psychiatr Res       Date:  1975-11       Impact factor: 4.791

3.  Movement Disorders Society Scientific Issues Committee report: SIC Task Force appraisal of clinical diagnostic criteria for Parkinsonian disorders.

Authors:  Irene Litvan; Kailash P Bhatia; David J Burn; Christopher G Goetz; Anthony E Lang; Ian McKeith; Niall Quinn; Kapil D Sethi; Cliff Shults; Gregor K Wenning
Journal:  Mov Disord       Date:  2003-05       Impact factor: 10.338

Review 4.  Mild cognitive impairment as a clinical entity and treatment target.

Authors:  Ronald C Petersen; John C Morris
Journal:  Arch Neurol       Date:  2005-07

5.  The National Alzheimer's Coordinating Center (NACC) Database: an Alzheimer disease database.

Authors:  Duane L Beekly; Erin M Ramos; Gerald van Belle; Woodrow Deitrich; Amber D Clark; Mary E Jacka; Walter A Kukull
Journal:  Alzheimer Dis Assoc Disord       Date:  2004 Oct-Dec       Impact factor: 2.703

Review 6.  Neuropsychiatric syndromes in dementia. Results from the European Alzheimer Disease Consortium: part I.

Authors:  Pauline Aalten; Frans R J Verhey; Marina Boziki; Roger Bullock; Eleanor Jane Byrne; Vincent Camus; Miriam Caputo; Debby Collins; Peter Paul De Deyn; Kazi Elina; Giovanni Frisoni; Nicola Girtler; Clive Holmes; Catherine Hurt; Anna Marriott; Patrizia Mecocci; Flavio Nobili; Pierre Jean Ousset; Emma Reynish; Eric Salmon; Magda Tsolaki; Bruno Vellas; Philippe H Robert
Journal:  Dement Geriatr Cogn Disord       Date:  2007-11-07       Impact factor: 2.959

Review 7.  Consistency of neuropsychiatric syndromes across dementias: results from the European Alzheimer Disease Consortium. Part II.

Authors:  Pauline Aalten; Frans R J Verhey; Marina Boziki; Andrea Brugnolo; Roger Bullock; Eleanor Jane Byrne; Vincent Camus; Miriam Caputo; Debby Collins; Peter Paul De Deyn; Kazi Elina; Giovanni Frisoni; Clive Holmes; Catherine Hurt; Anna Marriott; Patrizia Mecocci; Flavio Nobili; Pierre Jean Ousset; Emma Reynish; Eric Salmon; Magda Tsolaki; Bruno Vellas; Philippe H Robert
Journal:  Dement Geriatr Cogn Disord       Date:  2007-11-15       Impact factor: 2.959

Review 8.  A systematic review of neuropsychiatric symptoms in mild cognitive impairment.

Authors:  Roberto Monastero; Francesca Mangialasche; Cecilia Camarda; Sara Ercolani; Rosolino Camarda
Journal:  J Alzheimers Dis       Date:  2009       Impact factor: 4.472

Review 9.  Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium.

Authors:  I G McKeith; D W Dickson; J Lowe; M Emre; J T O'Brien; H Feldman; J Cummings; J E Duda; C Lippa; E K Perry; D Aarsland; H Arai; C G Ballard; B Boeve; D J Burn; D Costa; T Del Ser; B Dubois; D Galasko; S Gauthier; C G Goetz; E Gomez-Tortosa; G Halliday; L A Hansen; J Hardy; T Iwatsubo; R N Kalaria; D Kaufer; R A Kenny; A Korczyn; K Kosaka; V M Y Lee; A Lees; I Litvan; E Londos; O L Lopez; S Minoshima; Y Mizuno; J A Molina; E B Mukaetova-Ladinska; F Pasquier; R H Perry; J B Schulz; J Q Trojanowski; M Yamada
Journal:  Neurology       Date:  2005-10-19       Impact factor: 9.910

10.  Riluzole treatment, survival and diagnostic criteria in Parkinson plus disorders: the NNIPPS study.

Authors:  Gilbert Bensimon; Albert Ludolph; Yves Agid; Marie Vidailhet; Christine Payan; P Nigel Leigh
Journal:  Brain       Date:  2008-11-23       Impact factor: 13.501

View more
  13 in total

1.  Neuropsychiatric symptoms in early stage of Alzheimer's and non-Alzheimer's dementia, and the risk of progression to severe dementia.

Authors:  Tau Ming Liew
Journal:  Age Ageing       Date:  2021-09-11       Impact factor: 10.668

2.  Neuropsychiatric symptoms and caregiver relationship quality for older Mexican Americans.

Authors:  Phillip A Cantu; María P Aranda
Journal:  Aging Ment Health       Date:  2022-03-10       Impact factor: 3.514

3.  Subjective cognitive decline, APOE e4 allele, and the risk of neurocognitive disorders: Age- and sex-stratified cohort study.

Authors:  Tau Ming Liew
Journal:  Aust N Z J Psychiatry       Date:  2022-03-01       Impact factor: 5.598

4.  An Exploration of Subgroups of Neuropsychiatric Symptoms in Mild Cognitive Impairment and Their Risks of Conversion to Dementia or Death.

Authors:  Jiayue Qiu; Felicia C Goldstein; John J Hanfelt
Journal:  Am J Geriatr Psychiatry       Date:  2022-01-03       Impact factor: 7.996

5.  Depression, subjective cognitive decline, and the risk of neurocognitive disorders.

Authors:  Tau Ming Liew
Journal:  Alzheimers Res Ther       Date:  2019-08-09       Impact factor: 6.982

6.  Apathy as a Risky Neuropsychiatric Syndrome of Progression From Normal Aging to Mild Cognitive Impairment and Dementia: A Systematic Review and Meta-Analysis.

Authors:  Zili Fan; Luchun Wang; Haifeng Zhang; Xiaozhen Lv; Lihui Tu; Ming Zhang; Ying Zhang; Caihua Yan; Xin Yu; Huali Wang
Journal:  Front Psychiatry       Date:  2021-12-20       Impact factor: 4.157

7.  Neuropsychiatric symptoms in cognitively normal older persons, and the association with Alzheimer's and non-Alzheimer's dementia.

Authors:  Tau Ming Liew
Journal:  Alzheimers Res Ther       Date:  2020-03-31       Impact factor: 6.982

8.  Trajectories of subjective cognitive decline, and the risk of mild cognitive impairment and dementia.

Authors:  Tau Ming Liew
Journal:  Alzheimers Res Ther       Date:  2020-10-27       Impact factor: 6.982

9.  Subjective cognitive decline, anxiety symptoms, and the risk of mild cognitive impairment and dementia.

Authors:  Tau Ming Liew
Journal:  Alzheimers Res Ther       Date:  2020-09-11       Impact factor: 6.982

10.  Neuropsychiatric symptoms and subsyndromes in patients with different stages of dementia in primary care follow-up (NeDEM project): a cross-sectional study.

Authors:  Victoria García-Martín; M Canto de Hoyos-Alonso; Gloria Ariza-Cardiel; Rosalía Delgado-Puebla; Paula García-Domingo; Erika Hernández-Melo; Javier López de Haro-de Torres; Isabel Del Cura-González
Journal:  BMC Geriatr       Date:  2022-01-22       Impact factor: 3.921

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.